Targeting the Root, Not Just the Rhythm: Next-Generation Strategies for PKP2-ACM Powered by Lexeo
Description
Arrhythmogenic cardiomyopathy (ACM) is a rare, inherited cardiac disorder associated with ventricular arrhythmias, fibrofatty myocardial replacement, and sudden cardiac death (SCD). Mutations in the plakophilin-2 (PKP2) gene are the most common cause of ACM. Currently, there are no diseasemodifying therapies for PKP2-ACM; standard care focuses on arrhythmia control and SCD prevention through antiarrhythmics, ICDs, and ablation, without addressing the underlying cause.
Speakers

Moderator
Andrew Krahn

Speakers
Dominic Abrams
David Duncker
Fasial Merchant
Mina Chung
Harikrishna Tandri
Hawkins Gay
Mehak Dhande

Summary
Availability:
On-Demand
Expires on Sep 25, 2028
Cost:
FREE
 


HRX is a Heart Rhythm Society (HRS) experience. Registered 501(c)(3). EIN: 04-2694458.

Vision:
To end death and suffering due to heart rhythm disorders.

Mission:
To Improve the care of patients by promoting research, education, and optimal health care policies and standards.
© Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
 
Powered By